ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01855750
Brief Title: A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma

First Submitted : May 14, 2013
First Submitted that Met QC Criteria : May 14, 2013
First Posted : May 16, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : November 20, 2018
Last Update Posted : November 21, 2018